Long-Term Overall Survival From a Phase 1 Trial Using Intratumoral Plasmid Interleukin-12 With Electroporation in Patients with Melanoma

Authors

Adil Daud
Kathryn T. Takamura
Tu Diep
Richard Heller, Old Dominion UniversityFollow
Robert H. Pierce

Document Type

Presentation

Publication Date

2015

Publication Title

Journal of Translational Medicine

Volume

13 (Suppl 1):O3

Pages

1-1

DOI

10.1186/1479-5876-13-S1-O3

Comments

One-page outline of oral presentation from the Melanoma Bridge Meeting 2014, Naples, Italy. 03-06 December 2014.

Original Publication Citation

Daud, A., Takamura, K. T., Diep, T., Heller, R., & Pierce, R. H. (2015). Long-term overall survival from a phase I trial using intratumoral plasmid interleukin-12 with electroporation in patients with melanoma. Journal of Translational Medicine, 13 (Suppl 1):O3, 1-1. doi: 10.1186/1479-5876-13-S1-O

Repository Citation

Daud, Adil; Takamura, Kathryn T.; Diep, Tu; Heller, Richard; and Pierce, Robert H., "Long-Term Overall Survival From a Phase 1 Trial Using Intratumoral Plasmid Interleukin-12 With Electroporation in Patients with Melanoma" (2015). Bioelectrics Publications. 101.
https://digitalcommons.odu.edu/bioelectrics_pubs/101